| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | |
| S797923 | MACKLIN | 舒林酸 | 10mM in DMSO | 362元/1ml; | 咨询 |
|
| U0099 | TCI | Sulindac | >98.0%(T)(HPLC) | 595元/10G; 1785元/50G; | 咨询 |
基本信息 | 纯度/分析方法 | >98.0%(T)(HPLC) | | 分子式/分子量 | C20H17FO3S = 356.41 | | 外观与形状(20℃) | 固体 | | PubChem物质ID | 354334891 | | Merck Index (14) | 8982 | | MDL编号 | MFCD00599589 |
技术规格 | Appearance | Light yellow to Brown powder to crystal | | Purity(HPLC) | min. 98.0 area% | | Purity(Neutralization titration) | min. 98.0 % | | Melting point | 182.0 to 186.0 ℃ |
物性(参考值) | 熔点 | 184 ℃ | | 最大吸收波长 | 327(0.05mol/L methanolic HCl) nm | | 水溶性 | 不溶 | | 溶解度(极微溶) | 醇,甲醇 |
安全信息 | 图形或危害标志 |   | | 信号词 | 危险 | | 危险性说明 | H301 : 吞咽会中毒。 H361 : 怀疑对生育能力或胎儿造成伤害。 H317 : 可能造成皮肤过敏反应。 H334 : 吸入可能导致过敏或哮喘病症状或呼吸困难。
| | 防范说明 | P501 : 将内装物/容器送到批准的废物处理厂处理。 P261 : 避免吸入粉尘/烟/气体/烟雾/蒸气/喷雾。 P272 : 受沾染的工作服不得带出工作场地。 P270 : 使用本产品时不要进食、饮水或吸烟。 P202 : 在阅读并明了所有安全措施前切勿搬动。 P201 : 使用前取得专用说明。 P264 : 作业后彻底清洗皮肤。 P280 : 戴防护手套/穿防护服/戴防护眼罩/戴防护面具。 P284 : [在通风不足的情况下]戴呼吸防护装置。 P302 + P352 : 如皮肤沾染:用水充分清洗。 P308 + P313 : 如接触到或有疑虑:求医/就诊。 P362+P364 : 脱掉沾污的衣服,清洗后方可重新使用。 P304 + P340 : 如误吸入:将人转移到空气新鲜处,保持呼吸舒适体位。 P333 + P313 : 如发生皮肤刺激或皮疹:求医/就诊。 P301 + P310 + P330 : 如误吞咽:立即呼叫急救中心/医生。漱口。 P405 : 存放处须加锁。
|
相关法规 运输信息 | UN编号 | UN2811 | | 类别 | 6.1 | | 包装类别 | III | | 监管条件代码(*) | |
|
| 433895 | J&K | Sulindac | 98%, 一种COX抑制剂 | 90元/250MG; 204元/1G; 339元/5G; 2696元/50G; | 咨询 |
基本信息 | 分子式 | C20H17FO3S | | 分子量 | 356.41 | | MDL编码 | MFCD00599589 | | EINECS 编号 | 253-819-2 | | 存储条件 | Freezer -20℃ | 产品描述 Sulindac 是一种非甾体类的COX抑制剂,有效地抑制了前列腺素的合成,用来治疗急性或者慢性炎症。 靶点(IC50 & Targe) COX 体外研究 在两个结肠癌和其它细胞系中,Sulindac和其代谢物sulindac sulfide和sulindac sulfone也能抑制NF-κB途径,由于Sulindac介导的IKKbeta激酶活性的降低。[1]在长满和未长满的HT-29细胞中,Sulindac sulfide显著降低细胞数达4倍左右。Sulindac sulfid抑制多种来自其它组织,以及正常的上皮细胞和成纤维细胞来源的肿瘤细胞系的生长。[2]在CRC细胞系DLD1和SW480中,Sulindac sulfide抑制 beta-catenin/TCF介导的基因转录,并减少非磷酸化的beta-catenin的水平。[3] 体内研究 在鼠modelof家族性腺瘤性息肉病中,Sulindac不仅抑制肿瘤形成,而且降低小肠COX-2和前列腺素E(2)到基准水平,恢复细胞凋亡的正常水平。[4] 在Min/+小鼠肠组织中,Sulindac不仅减少95%肿瘤数,但不改变PGE 2和LTB 4的水平。在Min/+小鼠肠组织中,Sulindac降低肿瘤数目82%,而花生酸水平仍然在提升。[5] 在Min/+小鼠肠组织中,Sulindac引起4天之内70-80%的消退,但不具有对结肠损伤同样的影响。[6] 参考文献 [1] Yamamoto Y, et al. J Biol Chem,?999, 274(38), 27307-27314. [2] Piazza GA, et al. Cancer Res,?995, 55(14), 3110-3116. [3] Boon EM, et al. Br J燙ancer,?004, 90(1), 224-229. [4] Boolbol SK, et al. Cancer Res,?996, 56(11), 2556-2560. [5] Chiu CH, et al. Cancer Res,?997, 57(19), 4267-4273. [6] McEntee MF, et al. Carcinogenesis,?999, 20(4), 635-640. 安全信息 | 图形或危害标志 |   | | 提示语 | Danger | | 危险说明 | H301 H317 H334 H361 | | 防范说明 | P261 P280 P301+P310 P342+P311 | | UN号码 | 2811 | | 危险分类 | 6.1 | | 包装等级 | III | | WGK | 3 |
|
| S2180000 | | Sulindac | European Pharmacopoeia (EP) Reference Standard | 1250.01元/ ; | 咨询 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. 生化/生理作用 非甾体抗炎药;COX-1 的选择性抑制剂。 包装 Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. 注意 Please find SDS provided by EDQM here.. 其他说明 Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C20H17FO3S | | 分子量 | 356.41 | | MDL编号 | MFCD00599589 | | PubChem化学物质编号 | 329824512 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | EDQM | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | 储存温度 | 2-8℃ | | SMILES string | CC1=C(CC(O)=O)c2cc(F)ccc2\C1=C/c3ccc(cc3)S(C)=O | | InChI | 1S/C20H17FO3S/c1-12-17(9-13-3-6-15(7-4-13)25(2)24)16-8-5-14(21)10-19(16)18(12)11-20(22)23/h3-10H,11H2,1-2H3,(H,22,23)/b17-9- | | InChI key | MLKXDPUZXIRXEP-MFOYZWKCSA-N | | Gene Information | human ... PTGS1(5742), PTGS2(5743) |
安全信息 | 象形图 |   | | 警示用语: | Danger | | 危险声明 | H301 - H317 - H334 - H361 | | 预防措施声明 | P201 - P280 - P301 + P310 + P330 - P302 + P352 | | 危险分类 | Acute Tox. 3 Oral - Repr. 2 - Resp. Sens. 1 - Skin Sens. 1 | | 储存分类代码 | 6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects | | WGK | WGK 3 |
|
| S8139 | Sigma-Aldrich | Sulindac | ≥98.0% | 1122.16元/5 G; 3596.87元/25 G; | 咨询 |
产品说明 应用 处理人结肠癌细胞系可诱导 MRP1 和 MRP3,但不会诱导 MRP 家族的其他成员。据报道,可显着增加蒽环类药物(阿霉素、柔红霉素和表柔比星)以及替尼泊苷、VP-16 和长春新碱的细胞毒性。测试了舒林酸在体外对热诱导白蛋白变性的影响28,以及其与人血浆蛋白结合的能力。29 包装 5, 25 g in poly bottle 生化/生理作用 舒林酸是非甾体抗炎药,是具有抗增殖和凋亡作用的镇痛药。它抑制人结肠癌细胞中环氧合酶 2 的表达和活性25,26,并减轻腺瘤性息肉病患者的肿瘤负担。27 非甾体抗炎药;COX-1 的选择性抑制剂。 特点和优势 该化合物是由Merck & Co., Inc., Kenilworth, NJ, U.S.开发的。想要浏览其他由制药公司开发的化合物以及已批准药物/候选药物清单, 请单击此处。 这种化合物是ADME毒性研究的特色产品。点击此处发现更多特色ADME毒性产品。在sigma.com/discover-bsm可了解更多关于生物活性小分子的其他研究领域。 基本信息 | 经验(实验)分子式 | C20H17FO3S | | 分子量 | 356.41 | | EC 号 | 253-819-2 | | MDL编号 | MFCD00599589 | | PubChem化学物质编号 | 57654635 | | NACRES | NA.77 |
产品性质 | 质量水平 | 200 | | 生物来源 | synthetic (organic) | | 测定 | ≥98.0% | | 形式 | powder | | technique(s) | HPLC: suitable gas chromatography (GC): suitable | | 溶解性 | methanol: 50 mg/mL | | application(s) | forensics and toxicology veterinary | | 创始人 | Merck & Co., Inc., Kenilworth, NJ, U.S. | | SMILES string | CC1=C(CC(O)=O)c2cc(F)ccc2\C1=C/c3ccc(cc3)S(C)=O | | InChI | 1S/C20H17FO3S/c1-12-17(9-13-3-6-15(7-4-13)25(2)24)16-8-5-14(21)10-19(16)18(12)11-20(22)23/h3-10H,11H2,1-2H3,(H,22,23)/b17-9- | | InChI key | MLKXDPUZXIRXEP-MFOYZWKCSA-N | | Gene Information | human ... ALB(213), PTGS1(5742), PTGS2(5743) |
安全信息 | 象形图 |   | | 警示用语: | Danger | | 危险声明 | H301 - H317 - H334 - H361 | | 预防措施声明 | P201 - P280 - P301 + P310 + P330 - P302 + P352 | | 危险分类 | Acute Tox. 3 Oral - Repr. 2 - Resp. Sens. 1 - Skin Sens. 1 | | 储存分类代码 | 6.1D - Non-combustible, acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable | | 个人防护装备 | Eyeshields, Faceshields, Gloves, type P1 (EN143) respirator filter, type P3 (EN 143) respirator cartridges |
|
| Y0002255 | | Sulindac for system suitability | European Pharmacopoeia (EP) Reference Standard | 1341.2元/ ; | 咨询 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. 生化/生理作用 非甾体抗炎药;COX-1 的选择性抑制剂。 包装 Unit quantity: 15 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. 其他说明 Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C20H17FO3S | | 分子量 | 356.41 | | MDL编号 | MFCD00599589 |
产品性质 | manufacturer/tradename | EDQM | | 储存温度 | 2-8℃ | | SMILES string | CC1=C(CC(O)=O)c2cc(F)ccc2\C1=C/c3ccc(cc3)S(C)=O | | InChI | 1S/C20H17FO3S/c1-12-17(9-13-3-6-15(7-4-13)25(2)24)16-8-5-14(21)10-19(16)18(12)11-20(22)23/h3-10H,11H2,1-2H3,(H,22,23)/b17-9- | | InChI key | MLKXDPUZXIRXEP-MFOYZWKCSA-N |
安全信息 | 象形图 |   | | 警示用语: | Danger | | 危险声明 | H301 - H317 - H334 - H361 | | 预防措施声明 | P201 - P202 - P280 - P301 + P310 - P302 + P352 - P304 + P340 + P312 | | 危险分类 | Acute Tox. 3 Oral - Repr. 2 - Resp. Sens. 1 - Skin Sens. 1 | | 储存分类代码 | 6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| PHR3359 | Supelco | Sulindac | certified reference material, pharmaceutical secondary standard | 2020.96元/500 mg; | 咨询 |
产品说明 一般描述 Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards 生化/生理作用 非甾体抗炎药;COX-1 的选择性抑制剂。 分析说明 These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available. 其他说明 This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis. 基本信息 | 经验(实验)分子式 | C20H17FO3S | | 分子量 | 356.41 | | MDL编号 | MFCD00599589 |
产品性质 | 质量水平 | 300 | | 等级 | certified reference material pharmaceutical secondary standard | | 包装 | pkg of 500 mg | | 药典可追溯性 | traceable to PhEur S2180000 traceable to USP 1642008 | | 储存温度 | 2-30℃ | | SMILES string | CC1=C(CC(O)=O)c2cc(F)ccc2\C1=C/c3ccc(cc3)S(C)=O | | InChI | 1S/C20H17FO3S/c1-12-17(9-13-3-6-15(7-4-13)25(2)24)16-8-5-14(21)10-19(16)18(12)11-20(22)23/h3-10H,11H2,1-2H3,(H,22,23)/b17-9- | | InChI key | MLKXDPUZXIRXEP-MFOYZWKCSA-N |
安全信息 | 象形图 |   | | 警示用语: | Danger | | 危险声明 | H301 - H317 - H334 - H361 | | 预防措施声明 | P202 - P261 - P264 - P280 - P301 + P310 - P302 + P352 | | 危险分类 | Acute Tox. 3 Oral - Repr. 2 - Resp. Sens. 1 - Skin Sens. 1 | | 储存分类代码 | 6.1D - Non-combustible, acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| 1642008 | USP | Sulindac | United States Pharmacopeia (USP) Reference Standard | 3231.47元/200 MG; | 咨询 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia. 生化/生理作用 非甾体抗炎药;COX-1 的选择性抑制剂。 分析说明 These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. 其他说明 USP issued SDS can be found here. Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C20H17FO3S | | 分子量 | 356.41 | | MDL编号 | MFCD00599589 | | PubChem化学物质编号 | 329751211 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | USP | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | SMILES string | CC1=C(CC(O)=O)c2cc(F)ccc2\C1=C/c3ccc(cc3)S(C)=O | | InChI | 1S/C20H17FO3S/c1-12-17(9-13-3-6-15(7-4-13)25(2)24)16-8-5-14(21)10-19(16)18(12)11-20(22)23/h3-10H,11H2,1-2H3,(H,22,23)/b17-9- | | InChI key | MLKXDPUZXIRXEP-MFOYZWKCSA-N | | Gene Information | human ... PTGS1(5742), PTGS2(5743) |
安全信息 | 象形图 |   | | 警示用语: | Danger | | 危险声明 | H301 - H317 - H334 - H361 | | 预防措施声明 | P261 - P280 - P284 - P301 + P330 + P331 + P310 - P304 + P340 - P342 + P311 | | 危险分类 | Acute Tox. 3 Oral - Repr. 2 - Resp. Sens. 1 - Skin Sens. 1 | | 储存分类代码 | 6.1D - Non-combustible, acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| BP1041 | | Sulindac | British Pharmacopoeia (BP) Reference Standard | 2071.17元/50 MG; | 咨询 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia. 生化/生理作用 非甾体抗炎药;COX-1 的选择性抑制剂。 包装 Unit quantity: 50 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. 其他说明 Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C20H17FO3S | | 分子量 | 356.41 | | MDL编号 | MFCD00599589 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | BP | | 格式 | neat | | 储存温度 | 2-8℃ | | SMILES string | CC1=C(CC(O)=O)c2cc(F)ccc2\C1=C/c3ccc(cc3)S(C)=O | | InChI | 1S/C20H17FO3S/c1-12-17(9-13-3-6-15(7-4-13)25(2)24)16-8-5-14(21)10-19(16)18(12)11-20(22)23/h3-10H,11H2,1-2H3,(H,22,23)/b17-9- | | InChI key | MLKXDPUZXIRXEP-MFOYZWKCSA-N | | Gene Information | human ... PTGS1(5742), PTGS2(5743) |
安全信息 | 象形图 |   | | 警示用语: | Danger | | 危险声明 | H301 - H317 - H334 - H361 | | 预防措施声明 | P201 - P261 - P280 - P301 + P310 + P330 - P304 + P340 - P308 + P313 | | 危险分类 | Acute Tox. 3 Oral - Repr. 2 - Resp. Sens. 1 - Skin Sens. 1 | | 储存分类代码 | 6.1D - Non-combustible, acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| 219743 | Fluorochem | (Z)-2-(5-Fluoro-2-methyl-1-(4-(methylsulfinyl)benzylidene)-1H-inden-3-yl)acetic acid | 95% | 1166元/5g; 3432元/25g; 8536元/100g; | 咨询 |
基本信息 | CAS Number | 38194-50-2 | | MDL Number | MFCD00599589 |
安全信息 | 图形或危害标志 |    | | 危险性说明 | H301: Toxic if swallowed. H315: Causes skin irritation. H317: May cause an allergic skin reaction. H319: Causes serious eye irritation. H334: May cause allergy or asthma symptoms or breathing difficulties if inhaled. H335: May cause respiratory irritation. H361: Suspected of damaging fertility or the unborn child ..
| | 防范说明 | P201: Obtain special instructions before use. P202: Do not handle until all safety precautions have been read and understood. P233: Keep container tightly closed. P260: Do not breathe . P261: Avoid breathing P264: Wash hands thoroughly after handling. P270: Do not eat, drink or smoke when using this product. P271: Use only outdoors or in a well-ventilated area. P272: Contaminated work clothing should not be allowed out of the workplace. P280: Wear . P281: Use personal protective equipment as required. P285: In case of inadequate ventilation wear respiratory protection. P301 + P310: IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. P302 + P352: IF ON SKIN: Wash with plenty of soap and water. P304: IF INHALED: . P304 + P340: IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing. P304 + P341: IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. P305 + P351 + P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P308 + P313: IF exposed or concerned: Get medical advice/ attention. P312: Call a POISON CENTER or doctor/physician if you feel unwell. P321: Specific treatment (see . on this label). P330: Rinse mouth. P332 + P313: If skin irritation occurs: Get medical advice/ attention. P333 + P313: If skin irritation or rash occurs: Get medical advice/attention. P337 + P313: If eye irritation persists: Get medical advice/attention. P340: Remove victim to fresh air and keep at rest in a position comfortable for breathing. P342 + P311: If experiencing respiratory symptoms: Call a POISON CENTER or doctor/physician. P362: Take off contaminated clothing and wash before reuse. P363: Wash contaminated clothing before reuse. P403: Store in a well-ventilated place. P403 + P233: Store in a well-ventilated place. Keep container tightly closed. P405: Store locked up. P501: Dispose of contents/container to local regulations.
|
|